Abbott Laboratories stock has been punished hard in 2026, and the question is whether that punishment has overshot the ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories (ABT) kicked off Q1 2026 earnings season with a mixed report, where revenue grew ~8% year-over-year to $11.2 billion, beating the consensus by $160 million, driven primarily by a ...

Looking at the universe of stocks we cover at Dividend Channel, on 4/15/25, Buckle, Inc. (Symbol: BKE), AbbVie Inc (Symbol: ABBV), and Abbott Laboratories (Symbol: ABT) will all trade ex-dividend for ...

Abbott Laboratories, Inc. ABT has completed the world's first-in-human leadless left bundle branch area pacing (LBBAP) procedures. The landmark procedures were part of the prospective Leadless CSP ...

ABBOTT LABORATORIES insiders have traded $ABT stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...